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Introduction
Directed cellular migration facilitates the coordinated move-
ment of individual cells, cell clusters, and sheets of cells during 
development and regeneration. Directed cell migration is im-
portant for individual cells as well as groups of cells; there are 
key differences between these types of migrating cells. Individ-
ual cells migrating, either on a plastic dish or in a living tissue 
matrix, must correctly sense or respond to migratory cues. 
These cells then undergo changes in their cytoskeletal structure 
in order to project their cell bodies forward, put down new ad-
hesion complexes, and remove older adhesion complexes at the 
trailing end of the cell (Harden, 2002; Friedl et al., 2004; Blaser 
et al., 2005; Montell, 2006; Rørth, 2007). Although cells in a 
cluster or sheet must also respond to directional cues, they must 
also maintain the correct cell–cell adhesions and spatial aware-
ness in order to maintain their structure. Directed cluster migra-
tion forms the foundation for organ morphogenesis and, when 
abnormal, has been implicated in disease states such as mental 
retardation, birth defects, and cancer (Friedl et al., 2004; Kopfstein 
and Christofori, 2006). Insights into directed cell migration of 
groups of cells have come from the studies of relatively small 
clusters of cells, such as border cell migration during Drosophila 
oogenesis (Rørth, 2002; Montell, 2006) or the rearrangement 
of larger sheets, as is the case during vertebrate gastrulation 
(Keller, 2005). In Drosophila border cell migration, cell clusters 
initially become autonomously motile, elaborating nondirec-
tional actin-based cellular extensions with little net cellular dis-
placement. Border cell migration is mediated in response to 
local migratory cues emanating from the ovary via guidance   
receptors,  the  Drosophila  epidermal  growth  factor  receptor 
(DER) and the PDGF/VEGF-like (PVR) receptor, on the clus-
ter surface. Signaling through the receptors allows border cell 
membranes to become polarized to form actin-based mem-
brane extensions and migrate along the growth factor gradient 
(Bianco et al., 2007; Prasad and Montell, 2007). Genetic studies 
overexpressing DER in border cells indicate that it is not the   
total levels of receptor, but the location of activated receptors 
that determines directional migration (Jékely and Rørth, 2003). 
Despite its importance, our understanding of signaling mecha-
nisms downstream of the guidance receptors that operate in the 
context of developing organisms remains primitive.
Previous  work  points  to  a  central  role  for  guidance   
receptor endocytosis in interpreting local migratory cues to the 
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lthough directed cellular migration facilitates the 
coordinated movement of cells during devel-
opment and repair, the mechanisms regulating 
such  migration  remain  poorly  understood.  Missing-in- 
metastasis  (MIM)  is  a  defining  member  of  the  inverse 
Bin/Amphiphysin/Rvs domain (I-BAR) subfamily of lipid 
binding, cytoskeletal regulators whose levels are altered 
in a number of cancers. Here, we provide the first genetic   
evidence  that  an  I-BAR  protein  regulates  directed  cell 
migration  in  vivo.  Drosophila  MIM  (dmim)  is  involved 
in Drosophila border cell migration, with loss of dmim 
function resulting in a lack of directional movement by 
the border cell cluster. In vivo endocytosis assays com-
bined with genetic analyses demonstrate that the dmim  
product  regulates  directed  cell  movement  by  inhibiting   
endocytosis and antagonizing the activities of the CD2-
associated protein/cortactin complex in these cells. These 
studies demonstrate that DMIM antagonizes pro-endocytic 
components to facilitate polarity and localized guidance 
cue sensing during directional cell migration.
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Here, we provide the first in vivo genetic evidence for the 
involvement of an I-BAR family member in regulating direc-
tional migration. We show that MIM and cortactin antagonism 
underlies a novel molecular steering mechanism.
Results
Vertebrate MIM inhibits endocytosis
Increasing attention has been directed toward the role of the 
BAR  family  proteins  in  endocytosis  and  vesicle  trafficking.   
Because each subfamily of BAR proteins has been shown to 
positively regulate endocytosis, we sought to test whether I-BAR 
proteins function in a similar manner, or because they are struc-
turally distinct from the other families, do they act to antagonize 
endocytosis. We asked whether MIM, a founding member of 
the I-BAR family, regulates cell migration and endocytosis   
using well-characterized, receptor-mediated endocytosis assays 
in  vertebrate  cells.  Using  transferrin  endocytosis  assays,  we 
found the uptake of HRP-labeled transferrin within 5 min of 
cell warming to be increased where MIM protein levels are   
reduced (Fig. 1 A). Similar effects were seen when the kinetics 
of 
125I-labeled EGF uptake were observed after siRNA knock-
down of MIM (Fig. 1 B). This effect was not due to altered ini-
tial levels of receptor (Fig. 1, F and H). We also observed an 
increase in recycling levels of both transferrin and EGF (Fig. 1, 
C and D), consistent with the increase in 
125I-EGF uptake. These 
results indicate that a reduction in MIM protein levels increases 
endocytosis and recycling, but not receptor degradation, leading 
us to examine if MIM knockdown alters signaling downstream 
of the receptor. We tested this by assaying levels of phospho-
ERK1/2 (Fig. 1, G and I). In MIM knockdown cells, peak levels 
of pERK1/2 immunoreactivity remained unchanged, but the du-
ration of the signal persisted twice as long as in control cells. 
In our short-term cell-based assays we noted no differences in 
proliferation, adhesion, or overall morphology compared with 
control-treated cells (not depicted). We also found a marked 
abnormality in the ability of cells to directionally migrate in   
response to EGF (Fig. 1 E). From these data we conclude   
that MIM functions to inhibit receptor-mediated endocytosis,   
resulting in altered downstream signaling and reduced direc-
tional cell migration in vitro.
DMIM is a novel Drosophila I-BAR protein
Although MIM is one of the founding members of the I-BAR 
subfamily of lipid-binding BAR domain proteins, MIM func-
tions have not yet been delineated in vivo, although studies have 
been conducted with IRSp53 knockout mice (Kim et al., 2009; 
Sawallisch et al., 2009). Because the BAR subfamilies are rep-
resented in Dipterans, we chose to use Drosophila to better under-
stand the in vivo roles of these important proteins. Drosophila 
MIM (DMIM, GenBank/EMBL/DDBJ accession no. CG33558) 
shares strong identity in the I-BAR and WH2 domains with its 
vertebrate counterpart and ABBA, and less similarity with the 
I-BAR family member IRS53 (Fig. S1; Scita et al., 2008). 
Previous structural studies have demonstrated that MIM binds   
and bends phospholipid-containing membranes (Mattila et al., 
2007). To determine whether DMIM retains similar properties, 
underlying cytoskeleton. In cultured mammalian cells, localized 
receptor-mediated endocytosis and receptor recycling amplifies 
the guidance signal to focally activate key regulators of the cyto-
skeleton such as the GTPase Rac1 (Palamidessi et al., 2008). 
Similar mechanisms appear to control Drosophila border cell 
migration (Jékely et al., 2005; Minina et al., 2007). Forward 
genetic screens for migration mutants have identified cue-specific 
components such as the nonreceptor tyrosine kinase Src, com-
ponents of the endocytic machinery (Jékely et al., 2005; Palamidessi 
et al., 2008), and the CD2-associated protein (CD2AP)/cortactin 
complex (Lynch et al., 2003; Somogyi and Rørth, 2004). Each 
of these components has been shown to regulate endocytosis 
and cell migration, but little information exists about how they 
function to regulate directionality during migration.
Increasing  attention  has  been  directed  toward  the  Bin/
Amphiphysin/Rvs (BAR) superfamily of proteins and their role 
in  endocytosis  and  vesicle  trafficking  (Dawson  et  al.,  2006; 
Frost et al., 2007). Each of the BAR domain subfamilies of cur-
vature-dependent molecular scaffolds are thought to bring to-
gether effector complexes to distinct lipid surface in order to 
regulate actin cytoskeletal remodeling near vesicles. For exam-
ple, the BAR protein endophilin is critical for early vesicle scis-
sion and EGF receptor signaling (Kaneko et al., 2005), and 
isoforms have been associated with both tumor suppression and 
oncogenesis. Endophilin is recruited in a receptor-dependent 
manner through the formation of complexes with the Cbl- 
associated proteins CIN85 and CD2AP. The endophilin/CD2AP 
complex in turn mediates vesicle scission through the recruit-
ment of cortactin and the actin-polymerization machinery (Dikic, 
2002; Lynch et al., 2003; Kaksonen et al., 2006).
The newest family of BAR domain proteins is the inverse 
or IMD BAR (I-BAR) family. IMD proteins are defined by the 
proteins Missing-In-Metastasis (MIM) and the insulin receptor 
substrate 53 (IRSp53) cytoskeletal regulators (Miki et al., 2000; 
Lee et al., 2002). MIM was originally identified as a gene whose 
expression is down-regulated in a variety of urogenital meta-
static cancers (Lee et al., 2002; Wang et al., 2007), but other 
studies have also demonstrated elevated MIM levels in many 
hedgehog-dependent tumors (Callahan et al., 2004) and meta-
static endodermal tumors such as hepatocellular carcinomas 
(Ma et al., 2007). Like many BAR family proteins, MIM 
contains several protein–protein interaction modules that sug-
gest it functions to scaffold protein complexes at membranes 
(Mattila et al., 2003; Woodings et al., 2003; Gonzalez-Quevedo 
et al., 2005; Lin et al., 2005). Crystal structure analysis indi-
cates that the shape of the IMD dimer is the most convex of the 
family members thus far, suggesting that the I-BAR family senses 
a very distinct class of membranes (Lee et al., 2007). I-BAR 
family members have also been well studied as membrane-
deforming proteins with the capacity to cause membrane tubu-
lation and projections (Suetsugu et al., 2006; Mattila et al., 
2007; Saarikangas et al., 2008, 2009; Yang et al., 2009). Because 
each of the other BAR family members has roles in posi-
tively regulating endocytosis, the convex shape of the I-BAR 
proteins is proposed to be involved in antagonizing endocytosis, 
although this supposition has not been directly tested (Dawson 
et al., 2006; Lee et al., 2007).355 Missing-in-metastasis regulates endocytosis during cell migration • Quinones et al.
Figure 1.  Vertebrate MIM loss of function results in increased endocytosis and reduced directional migration. (A and B) Quantification of the ratio of 
internalized to surface-bound Transferrin (A) of EGF (B) in ptc
/ MEFs treated with indicated siRNAs. Data are represented as the mean ± SEM from three 
separate experiments (*, P < 0.01; t test). (C and D) Quantification of the amount of recycled Transferrin (C) or EGF (D) in the medium of ptc
/ MEFs 
treated with indicated siRNAs. Data are represented as the mean ± SEM from three separate experiments. Inset in C shows immunoblots of protein level 
knockdown after treatment with indicated siRNAs. (E) MIM knockdown alters EGF-induced directional cell migration. Transwell migration assays showing 
alterations in the migration of ptc
/ MEFs through a permeable membrane in response to an EGF or PDGF gradient over the course of 8 h. Data are 
represented as the mean ± SEM from three separate experiments (*, P < 0.01; t test). (F) EGFR levels in siRNA-treated cells show that si-MIM–treated cells 
do not display enhanced degradation of the EGF receptor over time. (G) Phospho-ERK1 and 2 levels in cells treated with control or MIM siRNA. MIM 
knockdown results in prolonged levels of pERK1/2 after the addition of EGF to the cell medium. (H and I) Quantification of immunoblots used for F and G. 
Data are represented as the mean ± SEM from three separate experiments (*, P < 0.01; t test).JCB • VOLUME 189 • NUMBER 2 • 2010   356
partial female sterility (Fig. S2, F and G). dmim mutant adults 
appear phenotypically normal, but display defects in locomotor 
activity (Fig. S2, H and I). We also observed that dmim mutants 
display marked abnormalities in guided cell migration. Two cell 
types requiring precise cellular movement during development 
are  the  ovarian  border  cells  and  the  primordial  germ  cells 
(PGCs) in the embryo. In the early embryo, PGCs respond to 
both maternal and zygotic cues from the mesoderm to trans-
migrate across an epithelial layer toward the genital mesoderm 
(Kunwar et al., 2006). dmim mutant PGCs fail to arrive at   
the mesodermal target despite apparently normal mesoderm   
as measured by Clift immunoreactivity (unpublished data).   
Approximately 10% of the PGCs arrest outside the embryo   
after germ band extension. Of those that enter, all are capable of 
transmigration, but only 20% appropriately migrate toward the 
gonadal mesodermal attractants. The remaining dmim PGCs 
demonstrate  a  metastatic  phenotype,  with  PGCs  scattered 
throughout the posterior embryo (Fig. 3, A and B).
In  the  ovary,  border  cells  also  perform  a  well-defined   
directional migration in response to oocyte-derived growth factor 
migratory cues (Rørth, 2002; Montell, 2006). The border cell 
cluster first migrates toward the posterior end of the egg cham-
ber, and then dorsally as the migratory cue changes position. 
dmim mutant border cell clusters have normal numbers and 
we compared the lipid-binding properties of purified fly and   
human MIM I-BAR domains (Fig. 2, B and C). Both human   
and DMIM proteins bound to PI(4,5)P2-containing vesicles, 
whereas the DMIM mutant I-BAR domain failed to bind to 
these vesicles. The DMIM I-BAR domain was also able to bind 
to PI(3,4,5)P3-containing vesicles, whereas the human I-BAR 
was not. This binding was quite specific as mutation of the con-
served lipid-binding motifs completely abrogated lipid binding 
(Mattila et al., 2007). Further, fly or human MIM overexpres-
sion in Drosophila S2 cells results in the same dramatic cyto-
skeletal reorientation and extensions (Fig. 2 D), indicating that 
DMIM functions similarly to its vertebrate orthologue.
Migration defects in dmim mutants
To understand the role of DMIM and other I-BAR family mem-
bers, we generated a dmim-null mutant through homologous re-
combination (Fig. 2 A). We confirmed that the dmim mutant 
lacked the conserved I-BAR domain and much of the scaffold-
ing domain (Fig. S2 A) and dmim/dmim phenotypes equaled 
those from dmim/deficiency mothers, arguing the dmim mutant 
is a strong loss-of-function mutant. The dmim locus produces 
a maternal transcript in the ovary, which is then distributed 
into the germ cells during early embryogenesis (Fig. S2, B–E). 
Consistent with this maternal expression, dmim mutants display 
Figure 2.  DMIM is the Drosophila homologue of human MIM. (A) The genomic structure of the dmim locus on chromosome 2R, 42C-42E, showing the 
transcriptional start (arrow) and exons encoding the I-BAR, scaffolding, and WH2 domains. The black box above indicates the exons (3–10) deleted by 
homologous recombination to make dmim-null flies. (B) Native gel of hMIM, DMIM, or DMIM mutant (4KA) I-BAR domains binding with lipids. Only when 
the I-BAR domain(s) bind to lipids will they run down the native gel. (C) hMIM, DMIM, or DMIM mutant (4KA) I-BAR domain cosedimented with PI(4,5)P2- or 
PI(3,4,5)P3-rich (30%) large multilamellar vesicles. Human and fly MIM display similar specificity in binding for specific lipids. (D) Overexpressing human 
or Drosophila MIM in Drosophila S2 cells results in similar changes in the actin cytoskeleton. Overexpression of either protein results in the formation of 
actin-based protrusions from the cell membrane. Bar = 20 µm.357 Missing-in-metastasis regulates endocytosis during cell migration • Quinones et al.
Figure 3.  dmim-null flies display abnormal cell migration. (A) Immunohistochemistry of Drosophila embryos at different developmental stages stained 
with anti-VASA antibody to highlight the progress of germ cell migration. dmim mutants display retained germ cells outside of the embryo at stage 9 and 
mislocalized germ cells in the mesoderm at stage 15. Red arrowheads indicate the position of the primordial germ cells throughout each stage. Bar = 50 µm. 
(B) Quantification of germ cell migration from two different developmental stages where dmim mutants display an aberrant migration pattern. (C) dmim 
mutants are delayed in migration of the border cells in stage 10 egg chambers. The egg chambers are stained with phalloidin (F-actin, red). Bar = 50 µm. 
(D) Expression of a UAS-DMIM-Myc transgene under the 306-Gal4 driver shows expression of the construct in the border cells in both the dmim mutant 
and wild-type backgrounds. White arrowheads indicate the border cell cluster. Bar = 50 µm. (E) Quantification of border cell migration using the scale 
described in F; more than 100 egg chambers were examined per genotype. (F) Schematic of a stage 10 egg chamber and scale used to score border cell 
migration defects. Anterior is to the left. (G) Border cell stained for pTyr (green) and F-actin (red) indicating the portion of the cell membrane where active 
signaling is occurring. Bar = 5 µm. (H) Quantification of the ratio of posterior to anterior pixel staining with the pTyr antibody. Initial polarized pTyr has 
been shown to be crucial for proper border cell migration (Jékely et al., 2005).JCB • VOLUME 189 • NUMBER 2 • 2010   358
Figure 4.  dmim mutants show border cell migration defects and altered endocytosis. (A) Time-lapse series of confocal micrographs of early stage 9 border 
cell clusters expressing UAS-GMA under 306-Gal4 in wild-type, dmim mutant, and dmim mutants expressing UAS-DMIM-Myc transgene in the border cells 
showing the migration of the border cell clusters over 3 h. White arrowheads indicate the border cell cluster and the dashed line indicates the anterior 
end of the oocyte (the end point of border cell migration). Bar = 50 µm. (B) Quantification of the directionality index (DI) of the border cell cluster. The   
DI is calculated as (A  B)/(A + B), where A is the number of forward extensions and B is the number of rearward extensions. Forward and rearward 
extensions are defined by which direction they point away from a vertical line on the dorsal ventral axis of the egg chamber. (C) Quantification of the 
migration speed of the border cell cluster, independent of the direction of migration. (D) Quantification of the average lifetime of each extension from the 
border cell cluster. All analyses were conducted using five separate movies for each genotype. (**, P < 0.001;***, P < 0.0001; t test). (E) Time-lapse 359 Missing-in-metastasis regulates endocytosis during cell migration • Quinones et al.
modes of border cell membrane dynamics: initial random ex-
tensions independent of cue direction, posterior-directed move-
ment characterized by long extensions toward the guidance cue 
source, and as the cluster comes closer to the guidance cue 
source, slower dorsal migration toward the oocyte nucleus. 
Border cells with constitutively active guidance receptors fail 
to detach from the anterior chamber and lack cell protrusions, 
whereas border cells with a lack of guidance receptor activity 
(i.e., those expressing dominant-negative receptors) have nor-
mal cytoplasmic extensions, but lack directional migration (Prasad 
and Montell, 2007).
To examine how the dmim product effects border cell mi-
gration, we imaged dmim mutant border cells expressing the   
actin-binding domain of moesin tagged with GFP (GMA) com-
pared with isogenic wild-type controls (Fig. 4 A; Video 1 [wt], 
Video 2 [dmim mutant], Video 3 [dmim;DMIM+ rescue]).   
Using a directional migration index (Prasad and Montell, 2007), 
we found that wild-type border cells displayed marked direc-
tionality toward the cue source, with a directionality index close 
to 1.0. These data emphasize the marked asymmetry of exten-
sions accompanying normal cluster migration. DMIM depletion 
impairs the directionality of the border cell cluster (Fig. 4 B), 
and phenocopies border cell clusters lacking guidance receptors 
(Prasad and Montell, 2007). Further, we ascertained the dura-
tion of the cytoplasmic extensions to determine whether dmim 
had affected the actin cytoskeleton itself. Measurement of the 
time to maximal extension or retraction in several independent 
movies clearly indicated no difference in extension lifetime, 
suggesting that dmim is not required for general actin dynamics 
in these cells in vivo (Fig. 4 D). Because the I-BAR proteins 
have been shown, when overexpressed, to promote formation of 
small filopodial-like plasma membrane protrusions in migrating 
cells, we assayed the number of small cellular projections on 
the cell surface of individual border cells over time (Fig. 4 E). 
Similar to our results with larger extensions, we observed no 
difference in the number of these fine projections (Fig. 4 F). The 
dmim mutants also displayed reduced migration speeds inde-
pendent of their direction, with dmim mutant border cells mov-
ing much slower. The average speed for dmim mutants was 
0.35 µm/min as compared with 0.65 µm/min displayed by wild-
type clusters (Fig. 4 C). Expression of DMIM back into the 
dmim mutant border cells (dmim;DMIM+) rescues both the 
directionality index and migration speed phenotypes. Live-cell 
imaging data in vivo lead us to conclude that DMIM plays a role 
in properly sensing and responding to directional migratory cues 
in an otherwise normal migratory environment.
DMIM inhibits endocytosis in border cells
Our in vitro data suggest that MIM inhibition of endocytosis under-
lies the inability to directionally sense guidance cues. To confirm 
size (Fig. S3 C), but are significantly delayed in the initial phase 
of polarized movement compared with their wild-type counter-
parts. By stage 10, nearly half of the mutant border cells are still 
delayed, whereas greater than 95% of wild-type clusters have 
traversed the egg chamber to the oocyte (Fig. 3, C and E).
We focused further on dmim function in the border cells 
because of the ease of genetic manipulation and live imaging in 
this system. To determine whether the dmim product functions 
in migrating cells or in the surrounding environment, we ana-
lyzed the structure of the dmim mutant ovary. The polarity, 
membrane, and cytoskeletal structure appeared to be unaffected 
as detailed by Fas2, oskar, armadillo, DE-cadherin, and phalloi-
din immunoreactivity (Fig. S3, A and B). Moreover, expression 
levels of the migratory cues such as gurken exhibited immuno-
reactivity comparable to wild type, arguing that dmim mutants 
retain a normal migratory environment. Because the dmim locus 
sits immediately adjacent to recombination sites on the second 
chromosome, the generation of dmim mutants specifically in 
border cells was not possible. Rather, we aimed to demonstrate 
cell autonomy by rescuing the dmim phenotype through expres-
sion  of  wild-type  DMIM  in  the  border  cells.  Expression  of 
DMIM in border cells resulted in uniform distribution of DMIM 
protein at both the leading and lagging edges of the migrating 
border cells (Fig. S3 D). This uniformly distributed expression 
restored the ability of the cluster to respond to its normal migra-
tory cues (Fig. 3 E). Further, we tested whether higher levels of 
DMIM expression altered border cell migration using two dif-
ferent lines, the slbo-Gal4 and 306-Gal4 drivers (Fig. S3 D). 
Gain-of-function dmim border cells expressing elevated levels 
of DMIM protein displayed normal cell shape and border cell 
migration (Fig. 3 D). Previous studies indicate that membrane 
response to directional guidance cues are polarized, as measured 
by phosphotyrosine (pTyr) staining at the leading edge. (Rørth, 
2002, 2007; Jékely et al., 2005). dmim mutant border cells fail 
to correctly polarize, as assayed by nonlocalized pTyr staining 
around the border cell membrane (Fig. 3, G and H). These data 
suggest that DMIM acts in migrating border and PGC cells to 
facilitate the initial membrane polarity as the border cells begin 
to migrate.
dmim mutant border cell migration 
phenocopies loss of guidance receptors
The study of cell dynamics during migration both in vitro and   
in vivo has been hampered by the lack of a natural environment to 
study cell movement or the necessity for fixation to observe the 
migratory cells. Using recent technical developments that allow 
live imaging of migrating border cell clusters, we examined the 
role for dmim in border cell motility in a native environment 
(Bianco et al., 2007; Prasad and Montell, 2007; Tekotte et al., 
2007). In vivo cell motility studies have observed three distinct 
series of confocal micrographs of individual border cells expressing UAS-GMA under 306-Gal4. Red arrowheads indicate tracking of a single cellular 
projection over time. Images were taken every 5 min, and the area shown is a magnification of the leading edge of a single border cell within a migrating 
cluster. (F) Quantification of the number of small surface projections in E. Data are represented as the mean ± SEM from 10 separate time series for each 
genotype. (G) Quantification of the amount of FM4-64 dye uptake over time for each indicated genotype. Data are represented as the mean ± SEM from 
five separate time series for each genotype. (H) Live confocal imaging of border cell clusters stained with the membrane-selective dye FM4-64. Each time 
series shows the gradual uptake and increase of the dye at the membrane of the border cells. Bar = 5 µm.
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Figure 5.  Loss of dcortactin or cindr rescues dmim border cell migration defects. (A) GST cosedimentation assay using candidate GST proteins and S2 
cell-derived DMIM protein. DMIM binds to itself, human MIM, and DCortactin. (B) Immunoprecipitation assay using an antibody to endogenous DCortac-
tin and lysates from Myc-tagged DMIM constructs. FL (full length DMIM); I-BAR (lacking the IBAR domain); PRD (lacking the polyproline-rich domain).   
(C) MIM or Cortactin knockdown alters EGF-induced directional cell migration. Transwell migration assays showing alterations in the migration of ptc
/ 
MEFs through a permeable membrane in response to an EGF or PDGF gradient over the course of 8 h. Data are represented as the mean ± SEM from 
three separate experiments (*, P < 0.01; **, P < 0.001; t test). (D) Schematic of a stage 10 egg chamber and scale used to score border cell migration 
defects. Anterior is to the left. (E) Confocal immunofluorescence images of egg chambers from wild-type, dmim, dcortactin, dmim; dcortactin, cindr RNAi, 
and dmim/cindr RNAi double-mutant egg chambers stained with phalloidin (F-actin, red). White arrowheads indicate the border cell cluster. Bar = 50 µm. 
(F and H) Quantification of stage 10 border cell migration for the indicated genotypes; more than 100 egg chambers were examined per genotype.   361 Missing-in-metastasis regulates endocytosis during cell migration • Quinones et al.
We determined the functional relationship between DMIM 
and Dcortactin through the examination of border cell phe-
notypes in double mutants. Previous analysis of dcortactin  
mutants identified a mild border cell migration phenotype 
(Somogyi and Rørth, 2004), a phenotype we confirmed (Fig. 5, 
E and F). Surprisingly, we found that dmim; dcortactin double 
mutant border cells do not enhance the mutant phenotype, but 
rather display a wild-type phenotype. This suggests that DMIM 
acts antagonistically to Dcortactin to regulate directional cell 
migration in border cells. Because cortactin is recruited to en-
dophilin via the adapter CD2AP (Dikic, 2002; Soubeyran et al., 
2002;  Lynch  et  al.,  2003),  if  the  CD2AP/cortactin  complex 
functions antagonistically to MIM in guided migration, then 
CD2AP  mutant  border  cells  should  phenocopy  dcortactin  
mutants, and also rescue the dmim mutant border cell cluster 
migration phenotype. We assayed the effects of mutations in the 
single fly CD2AP gene, cindr, on border cell migration. Previ-
ous  studies  have  indicated  that  two  cindr
i  lines  have  strong   
effects on photoreceptor cell morphology (Johnson et al., 2008). 
We expressed these two independent cindr
i lines in border cells, 
where they demonstrated a moderate border cell migration phe-
notype, mimicking that of dcortactin mutants (Fig. 5, E and H). 
Like dcortactin, cindr
i expression in a dmim mutant background 
partially restores the ability of border cell clusters to migrate, 
increasing the fraction of clusters that have migrated more than 
half the distance to the oocyte. We also found that the loss of 
dcortactin or cindr results in a mild reduction in the uptake of 
the FM4-64 dye in border cells (Fig. 5, G and I). As predicted, 
knockdown of dmim in combination with either dcortactin or 
cindr results in a partial rescue of the dmim increase in dye   
uptake. From these data, we conclude that the cindr/Dcortactin 
complex acts to promote endocytosis in opposition to that   
of DMIM.
Our genetic data suggest guided cell migration is regu-
lated in part from competition for cortactin between the pro- 
endocytic BAR domain complex endophilin/CD2AP, and the 
anti-endocytic BAR MIM. To confirm this model, we examined 
MIM antagonism of cortactin and other endocytic regulators in 
cultured vertebrate cells to determine whether double mutants 
would also restore normal receptor uptake in vitro. As predicted, 
whereas treatment with siRNA against cortactin decreases the 
levels of EGF receptor endocytosis, siRNA-mediated knock-
down of both MIM and cortactin restores receptor uptake levels 
back to those in the control-treated cells (Fig. 6 A). Consistent 
with our genetic data, combination knockdowns of MIM with 
CD2AP also restore EGF uptake levels to control values. We 
further tested whether MIM antagonism extended to other   
endocytic regulators. Knockdown of endophilin leads to a 
reduction in endocytosis with the combined knockdown of en-
dophilin and MIM demonstrating a reproducible trend in eleva-
tion of endocytosis over endophilin alone. Knockdown of Cbl, 
clathrin, or dynamin results in decreased endocytosis and is not 
our in vitro results, we examined border cell membrane dynamics 
using a live-cell lipophilic dye uptake assay, previously used to 
measure clathrin-dependent endocytosis rates during Drosophila 
synaptic reuptake (Verstreken et al., 2008). We confirmed the 
dynamin dependence of dye uptake by showing dramatic reduc-
tion of dye uptake in clusters expressing dominant-negative 
dynamin (slbo-Gal4; shi
K44A), or those treated with the dyna-
min inhibitor Dynasore (Georgiou et al., 2008; Kirchhausen 
et al., 2008; Fig. 4, G and H). If MIM inhibits receptor-mediated 
endocytosis, we would expect increased dye uptake in border 
cells lacking DMIM. During live imaging the dye is taken up 
throughout the entire egg chamber, including the border cells, 
and continues to increase after dye addition. However, in dmim 
mutants, the rate of dye uptake compared with wild type was 
dramatically increased (Fig. 4 G). This effect was not simply 
due to an increase in general membrane uptake or permeability, 
as the increased uptake was dynamin dependent and expression 
of the wild-type DMIM protein in mutant border cells partially 
rescued the uptake phenotype. The live-cell imaging data, in con-
junction with dye uptake studies, support the idea that DMIM 
regulates guided cell migration through its ability to inhibit 
receptor-mediated endocytosis.
MIM competes with endophilin/CD2AP for 
binding to cortactin
BAR domain proteins function through regulating the assem-
bly of protein complexes at membrane surfaces (Ren et al., 
2006; Machesky and Johnston, 2007). To understand mecha-
nistically how dmim regulates border cell guidance sensing, 
we sought to discover which proteins, previously known to 
regulate border cell migration, interact with the scaffolding 
portion of DMIM. In GST pull-downs and coimmunoprecipi-
tation  assays,  DMIM  formed  protein  complexes  with  Dro-
sophila  cortactin  (Dcortactin),  but  not  with  Rac1,  Cdc42, 
several  RPTPs,  and  the  BAR  domain  protein  amphiphysin 
(Fig. 5 A). Dcortactin is a major Src phosphorylation target 
downstream of growth factor signaling and is part of the pro-
endocytic  complex  comprised  of  the  BAR  domain  protein   
endophilin and its binding partner CD2AP. The endophilin/
CD2AP/cortactin complex helps to provide force for endo-
cytosis and scission of the early endosome by inducing local 
actin polymerization. Like their vertebrate counterparts, DMIM 
interacts  with  Dcortactin  through  the  proline-rich  domain 
(Fig. 5 B). Both MIM and cortactin also affect the directional 
migration  of  vertebrate  cells  in  culture.  Cells  treated  with 
siRNA against either MIM or cortactin display a reduction in 
cell  motility  in  response  of  EGF  (Fig.  5  C).  Simultaneous 
knockdown of both MIM and cortactin results in normal cell 
motility, suggesting that these two proteins work antagonisti-
cally. The loss of both proteins resulting in a wild-type pheno-
type also suggests that there is redundancy with another set of 
proteins with a similar function.
(G and I) Quantification of the amount of FM4-64 dye uptake over time for each indicated genotype. Data are represented as the mean ± SEM from three 
separate time series for each genotype. Knockdown of dmim in combination with either dcortactin or cindr is able to partially rescue the increase in dye 
uptake seen in the dmim mutant border cells.
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rescued in combination knockdowns with MIM, suggesting that 
MIM acts uniquely through CD2AP/cortactin (Fig. 6 A). These 
results, along with previous studies, suggest that endophilin 
could be interacting with additional proteins when CD2AP and 
cortactin are unavailable during EGFR endocytosis (Soubeyran 
et al., 2002; Schmidt et al., 2003; Kaneko et al., 2005; Gareus 
et al., 2006; Uezu et al., 2007).
Because circular dorsal ruffles (CDRs) and cortactin have 
been shown to be an alternative endocytosis pathway for the in-
ternalization of growth factor receptors, we investigated MIM 
and  cortactin’s  role  in  CDR  formation  (Lynch  et  al.,  2003;   
Bompard et al., 2005; Orth et al., 2006; Machesky and Johnston, 
2007; Teodorof et al., 2009). In vivo, we found no evidence   
for CDR formation in migrating border cells. In cultured cells   
(Fig. S4), we observed that the loss of MIM resulted in a reduction 
of the CDR formation in response to both PDGF-BB and 
EGF. However, in contrast to border cells, EGF endocytosis in 
our MIM and cortactin double mutant cells failed to rescue 
CDR formation. These results suggest that the effects seen in 
border cell migration are not a result of increased internaliza-
tion of the growth factor receptors due to dorsal ruffle forma-
tion (Fig. S4 C).
We examined the kinetics of cortactin association with 
guidance cue addition by performing cortactin immunoprecipi-
tations upon the addition of EGF ligand. Under serum-free   
conditions, we find that cortactin associates with both endophilin/
CD2AP and MIM complexes, but within 5 min after EGF 
addition, cortactin begins to disassociate from the CD2AP/
endophilin complex (Fig. 6 C; Lynch et al., 2003). In the absence 
of MIM, cortactin fails to dissociate from CD2AP after EGF 
Figure 6.  MIM regulates endocytosis by competing with CD2AP for cortactin binding. (A) Quantification of the ratio of internalized to surface-bound 
EGF at 0 and 15 min in ptc
/ MEFs treated with the indicated siRNAs. MIM knockdown shows an increase in EGF uptake, whereas cortactin or CD2AP 
knockdown shows a decrease in EGF uptake after 15 min. The combination of siRNAs against both MIM and cortactin or MIM and CD2AP restores the 
phenotype to wild-type levels at 15 min. The phenotype is not restored by simultaneous knockdown with clathrin heavy chain, dynamin, cbl, or endophilin. 
Data are represented as the mean ± SEM from three separate experiments (*, P < 0.01; t test). (B) Immunoblots indicating the level of protein knockdown 
after treatment with siRNAs for A. (C) Coimmunoprecipitations of CD2AP and endophilin with cortactin in si-GFP– or si-MIMtreated ptc
/ MEF lysate 
showing a decrease in the association of both proteins with cortactin after EGF stimulation. In the si-MIM–treated cells, a prolonged association of CD2AP 
and endophilin with cortactin is seen when compared with si-GFP–treated cells. (D) Direct competition between in vitro–translated CD2AP and bacterially 
expressed MIM for the SH3 domain of cortactin. MIM lacking the region that binds cortactin (MIM 1–277) is unable to compete with CD2AP for cortactin 
binding. (E) Coimmunoprecipitations of GFP-tagged endophilin or GFP-tagged MIM with cortactin in NIH 3T3 cells treated with increasing concentrations 
of EGF ligand. The interaction between endophilin and cortactin quickly increases within 5 min after stimulation with EGF, and subsequently dissociates 
within 30 min. The interaction between MIM and cortactin increases within 5 min, but persists strongly even 30 min after stimulation when compared 
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but dmim mutants display a wild-type number of border cells. 
This discrepancy could be explained in part due to the obser-
vation that MIM associates with vertebrate Suppressor of Fused 
(Callahan et al., 2004), which is redundant in flies. The data 
presented here uncover migratory defects in PGCs, border cells, 
and vertebrate cultured fibroblasts, all responding to different 
migratory cues. This suggests that although cells use different 
cues and receptors for migration in a variety of systems, the 
regulation of this process at the level of endocytosis appears to 
be shared.
Our studies identify DMIM as novel I-BAR protein, and 
one of the first negative regulators of endocytosis with a role in 
guided cell migration. Genetic, cell biological, and biochemical 
data support the model that DMIM and CD2AP compete for 
cortactin in regulating receptor-mediated endocytosis. The 
observation that removing both MIM and cindr/cortactin results 
in wild-type migration suggests that MIM and cortactin consti-
tute one of several redundant regulatory systems to control the 
directional migration of the border cells. Because removal of 
both proteins restores normal border cell migration but disrup-
tion of clathrin and dynamin function does not, we speculate 
that other combinations of pro- and anti-endocytosis complexes 
downstream of dynamin must be operating to balance this pro-
cess in migrating cells. Although we see a trend in increased en-
docytosis with MIM/endophilin double knockdown, the lack 
of complete rescue further suggests endophilin possesses MIM-
independent endocytosis functions. Current studies are ongoing 
to identify these additional signaling pathways in the sensi-
tized dmim;dcortactin background. More importantly, our data 
show the dramatic effects on migration when components of the 
steering mechanism are missing or out of balance. Similar 
effects have also been seen with gross overexpression of cortac-
tin (Timpson et al., 2005) and may explain the relatively high   
frequency of cortactin and MIM alterations in late-stage cancers 
(Patel et al., 1996; Lee et al., 2002; Timpson et al., 2007;   
Hofman et al., 2008).
These results provide a new mechanistic understanding 
of BAR domain function by showing that directional sensing 
comes in part from protein complexes competing for common 
effector proteins during endocytosis. These data support the   
notion that MIM acts to dampen guidance receptor signaling at 
a  variety  of  ligand  concentrations  by  sequestering  cortactin. 
Guidance cue binding assembles the N-BAR subfamily mem-
ber endophilin and its adapter CD2AP, which binds cortactin, 
shifting it away from MIM sequestration. We postulate that in-
creased endocytosis and MIM’s persistent binding of cortactin 
prevent the cell from improperly sensing guidance cues and 
misinterpreting directional differences. Previous studies sug-
gest that phosphorylation of cortactin modulates its interaction 
with a number of proteins (Zhu et al., 2007); however, we do not 
detect such alteration using phosphospecific cortactin anti-
bodies in our system (unpublished data). Consistent with this 
data are the lack of localized bulk MIM protein at the leading   
edge  of  cultured  cells  or  rescued  dmim;  DMIM+  border   
cells. Altogether, these data suggest that there is a novel MIM- 
dependent steering mechanism that guides cell migration through 
interactions with other protein complexes. Jékely et al. (2005)  
addition, resulting in an increase of the amount and duration of 
endophilin/CD2AP in complex with cortactin (Fig. 6 C). The 
duration of cortactin association mirrors that of the persistent 
pERK1/2 immunoreactivity (Fig. 1, H and J). Our work and 
other  studies  indicate  that  both  CD2AP  and  MIM  associate 
through their proline-rich domains with cortactin’s SH3 domain 
(Fig. 5 B; Lynch et al., 2003; Lin et al., 2005). Indeed, in vitro–
translated CD2AP readily associates with the purified SH3 do-
main of cortactin. Increasing concentrations of purified MIM 
abrogate the binding of cortactin to CD2AP (Fig. 6 D), support-
ing a direct competition between MIM and CD2AP for cortac-
tin binding. MIM lacking its proline-rich domain (MIM 1–277) 
fails to compete with CD2AP, providing additional support for 
the idea that MIM antagonizes the ability of cortactin to associ-
ate with the pro-endocytic CD2AP/endophilin complex. We 
then used stable GFP-tagged MIM and endophilin lines to ex-
amine cortactin association with each of the proteins at different 
EGF ligand concentrations over time. The antagonism between 
MIM and CD2AP/endophilin for cortactin binding could be ex-
plained  by  the  prolonged  association  between  cortactin  and 
MIM, which persists longer after stimulation with EGF ligand 
than the association between endophilin and cortactin, even at 
different ligand concentrations (Fig. 6 E).
Discussion
We have shown through genetic interaction and live-cell imag-
ing that migrating cells use a MIM-dependent steering mecha-
nism to interpret local migratory signals. MIM’s role appears to 
be general, as both border cell and PGC migration are affected 
in dmim mutants and involve different cell types responding to 
different guidance cues. Our data indicate that MIM inhibits 
guidance receptor endocytosis by competing directly with 
CD2AP for cortactin, resulting in dampened guidance receptor 
signaling. This study provides the first genetic and biochemical 
evidence for the function of a member of the I-BAR family of 
proteins in directed cell migration, and provides a mechanistic 
link between MIM and cell migration.
Directional cell migration is a complex process requiring 
dynamic rearrangements of the cytoskeleton and precise direc-
tional  sensing  of  local  migratory  cues  (Prasad  and  Montell, 
2007).  Our  live-cell  imaging  data  suggest  that  DMIM  is   
involved in directing cell migration through the inhibition of 
endocytosis. Although previous studies demonstrate that MIM 
is an actin cytoskeletal remodeling protein (Gonzalez-Quevedo 
et al., 2005; Lee et al., 2007; Mattila et al., 2007), our imaging 
studies argue against a major, direct role for MIM in general   
actin polymerization. Consistent with this notion is the lack of 
apparent defects in adherens junctions, the actin cytoskeleton, 
or anteroposterior polarity in dmim mutant egg chambers. This 
is not to say that MIM does not affect the actin cytoskeleton in 
other cases of cell migration, just that in the case of Drosophila 
border cell migration the function of DMIM is not required for 
actin cytoskeletal dynamics. Previous studies have also implicated 
MIM in regulating Sonic Hedgehog signaling (Callahan et al., 
2004). Mutations in the hedgehog pathway component costal2 
result in aberrant border cell numbers (Liu and Montell, 1999), JCB • VOLUME 189 • NUMBER 2 • 2010   364
North  Carolina,  Chapel  Hill,  NC).  The  primers  used  were,  5-CCC-
GGGAGCGAGTGAGGACGCGCAAATGG-3  and  5-GGTACCGAC-
CAGTTCCTGGGCCACAGAC-3 to amplify the 5 region and 5-AGATC-
TAGTCAGGTGAGAGTAGGAAATC-3  and  5-GAATTCCTGCCACAC-
GCTCCCATTCCATATCC-3 to amplify the 3 region. Mutant chromosomes 
were out crossed to yw flies for five generations to minimize linked enhanc-
ers and suppressors. DMIM rescue lines were made by cloning the dmim 
cDNA into the pUAST or pUASp vectors with a myc-his epitope tag on the 
C  terminus.  Transgenic  lines  were  generated  using  standard  methods. 
Transgenic lines were crossed into the 306-Gal4 (Bloomington Drosophila 
Stock Center, Bloomington, IN) for expression in the border cells. The slbo-
Gal4 and shi
K44A lines were obtained from the Bloomington Drosophila 
Stock Center. UAS-cindr-IR
2.21A + 2.23A (cindr IR
2) targets the long and inter-
mediate cindr transcripts and UAS-cindr-IR
3.73B + 3.81A (cindr IR
3) targets all 
three transcripts, as described previously (Johnson et al., 2008). The 
Cortactin
M7 line has been described previously (Somogyi and Rørth, 2004).
In vitro migration assays
For directional cell migration assays in vitro, cells were seeded into the   
upper compartment of a Transwell 12-well plate (Costar 3403; Corning) in 
serum-free medium after 16 h of serum starvation. The lower compartment 
of each well contained serum-free medium with or without the indicated 
growth factor. Cells were allowed to migrate for 8 h, then the medium was 
removed and the cells were fixed with 4% paraformaldehyde. Fixed cells 
were stained with 0.5% crystal violet and the cells in the upper compart-
ment were scraped off of the insert membrane. The well was then exten-
sively washed with water and allowed to air dry. Only cells that migrated 
down through the porous membrane remained. The crystal violet remaining 
in these cells was then extracted with 30% acetic acid and assessed by 
measuring the absorbance at 590 nm.
Lipid vesicle cosedimentation assays
6XHis fusion proteins of DMIM I-BAR (aa 1–477), hMIM I-BAR (aa 1–255), 
and DMIM
4KA I-BAR were cloned by standard techniques in pQE80L vector, 
expressed in bacteria and purified on Superflow Nickel Beads (QIAGEN). 
DMIM
4KA contained mutations K139A, K140A, K149A, and K150A gen-
erated by QuikChange Mutagenesis (Stratagene). PI(4,5)P2 (l--phosphati-
dylinositol-4,5-bisphosphate; porcine brain, tri-ammonium salt), PI(3,4,5)P3 
(1,2-dileoyl-sn-glycero-3-[phosphoinositol-3,4,5-trisphosphate], tetra-ammonium 
salt), phosphatidylserine (PS; brain), phosphatidylcholine (PC; brain), and 
phosphoethanolamine (PE) were purchased from Avanti Polar Lipids, Inc. 
Fusion proteins were diluted to desired concentrations in F-buffer (10 mM im-
idazole, pH 7.5, 0.2 mM CaCl2, 0.2 mM ATP, 1 mM DTT, 100 mM KCl, 
2 mM MgCl2, and 1 mM EGTA). For vesicle cosedimentation assays the 
following mixtures were prepared: 5% PE, 20% PS, 45–75% PC, and 
0–30% PI(4,5)P2 or PI(3,4,5)P3. Samples were vacuum dried under N2 and 
hydrated for a minimum of 4 h in 0.2 mM Hepes-KOH, pH 7.5, and 100 mM 
NaCl to a 1-mM total lipid concentration. Large multilamellar vesicles were 
formed by repeated freeze/thaw cycles between liquid nitrogen and a hot 
water bath. Vesicles were also vortexed before each experiment. I-BAR 
constructs were diluted in desired concentrations in F-buffer and sedimented 
at 360,000 g for 30 min at room temperature. For native gel electropho-
resis, fusion proteins were diluted to desired concentration in F-buffer. 
Lipid/protein reactions were incubated at room temperature for 1 h, run on 
12% native PAGE gels, stained with Coomassie, and scanned.
Drosophila egg chamber immunofluorescence
For confocal immunofluorescence, ovaries from 1–2-d-old females were 
dissected in PBS, fixed, and permeabilized in 4% paraformaldehyde and 
PBSX (0.1% Triton X-100) for 20 min at room temperature and subsequently 
washed in PBSX, blocked in 5% normal horse serum (Vector Laboratories), 
and then incubated overnight in primary antibody at 4°C. The primary 
antibodies used were: mouse anti-armadillo (1:200; Developmental Studies 
Hybridoma Bank [DSHB], Iowa City, IA), mouse anti-Myc (1:100; Sigma-
Aldrich), phalloidin-AF633 (1:100; Invitrogen), mouse anti-DE cadherin 
(1:250; DSHB), mouse anti-oskar (1:250; DSHB), mouse anti-lectin FITC 
(1:250; Vector Laboratories), mouse anti-FasIII (1:500; DSHB), mouse anti-
gurken (1:100; DSHB), rabbit anti-DCortactin (1:250; a gift from Dr. Togashi, 
Tohoku University, Sendai, Japan), mouse anti-GFP (1:250; Sigma-Aldrich), 
and phalloidin-TRITC (1:100; Sigma-Aldrich). Alexa Fluor–conjugated anti-
bodies (Invitrogen) were used as secondaries.
Drosophila egg chamber live imaging
For live confocal imaging, egg chambers from ovaries were prepared ac-
cording to previous protocols (Bianco et al., 2007; Prasad and Montell, 
2007; Tekotte et al., 2007) with some modification. Egg chambers were 
demonstrated the importance for regulating both polarity and a 
localized response to external stimuli during the migration of 
the border cell cluster. Their studies focused on regulation of 
receptor tyrosine kinase signaling through the action of key pro-
teins involved in the endocytosis of the receptor. We have fo-
cused our studies on a negative regulator of endocytosis, which 
in the Drosophila border cell cluster regulates both polarity and 
a local response to guidance cues as a means of mediating direc-
tional migration.
Materials and methods
Transferrin internalization and recycling
Ptc1-null mouse embryonic fibroblasts (MEFs; Taipale et al., 2000) were 
used throughout these studies due to the increased levels of MIM protein 
expressed when compared with NIH 3T3 cells, as well as the ease of MIM 
knockdown at the protein level in these cells. Ptc1-null MEFs were nucleo-
fected with the appropriate siRNA 2 d before the endocytosis assays, and 
were serum starved overnight before the assays. Endocytosis was mea-
sured using HRP-conjugated mouse Transferrin (Tfn; Sigma-Aldrich) and   
detected using a Sensolyte ADHP HRP ELISA Assay kit (AnaSpec). To mea-
sure the amount of internalized HRP-Tfn, cells were serum starved over-
night, the HRP-Tfn (100 µg/ml) in serum-free DME was added to each well, 
and the plate was placed at 37°C for the indicated time(s). Endocytosis 
was stopped by placing the plate on ice, washing with ice-cold PBS,   
pH 5.0, for 2 min each, and then 4 times with PBS, pH 7.0. The cells were 
then lysed in 20 mM Hepes, pH 7.9, 150 mM NaCl, and 1% NP-40 for 
10 min on ice. The amount of HRP-Tfn in the lysate was then measured   
following the Sensolyte kit protocol. To measure recycling of HRP-Tfn, cells 
were treated as per the above protocol. After stripping the unbound ligand 
from the cell surface, fresh serum-free medium was placed on the cells.   
Medium was then collected from the wells at the indicated time points and 
assayed for HRP-Tfn content following the Sensolyte kit protocol.
EGF stimulation, internalization, and recycling
For the EGF stimulation, Ptc1-null MEFs were grown for 2 d after nucleofec-
tion and then serum starved overnight. Cells were stimulated with EGF at 
100  ng/ml  (Sigma-Aldrich)  in  serum-free  DME  for  the  indicated  times, 
washed twice with PBS, and lysed. Lysates were loaded onto SDS-PAGE 
gels for Western blot analysis. The primary antibodies used were: rabbit 
anti-cortactin (1:1,000; Millipore), mouse anti–-actin (1:10,000), rabbit 
anti-MIM (1:500), mouse anti-CD2AP (1:500; Santa Cruz Biotechnology, 
Inc.), mouse anti-endophilin (1:1,000; Abcam), rabbit anti-dynamin (1:1,000; 
Abcam), rabbit anti-clathrin heavy chain (1:1,000; Abcam), and goat anti-
CBL (1:1,000; Abcam).
For 
125I-EGF assays, ptc1-null cells were grown for 2 d after nucleo-
fection and then serum starved overnight. After serum starvation, the cells 
were stimulated with EGF (100 ng/ml) in serum-free DME for the indicated 
times. Radiolabeled EGF at 1 ng/ml, (NEX1600; PerkinElmer) was com-
bined with unlabeled EGF to a final concentration of 100 ng/ml. For inter-
nalization assays, unbound ligand was removed by washing three times 
with ice-cold buffer containing: 20 mM Hepes, 130 mM NaCl, 5 mM KCl, 
0.5 mM MgCl2, 1 mM CaCl2, and 1 mg/ml polyvinylpyrolidione, pH 7.4. 
Surface-bound ligand was then collected in ice-cold acid strip buffer (50 mM 
glycine-HCl, 100 mM NaCl, and 1 mg/ml polyvinylpyrolidione, pH 3.0) 
for 2 min. Internalized ligand was then released with 5 N NaOH for 30 min, 
added to reducing sample buffer, and analyzed with a scintillation counter. 
For recycling assays, unbound ligand was removed as described above, 
then fresh serum-free medium was added to the cells. The cells were placed 
at 37°C for the indicated times. At each time point, medium was removed 
from the well and assayed for EGF content. Results were normalized to the 
initial amount of EGF in the medium at time 0. All siRNAs were ordered 
from  Thermo  Fisher  Scientific;  si-MIM:  5-GCAAGGCACUCAUCGAA-
GAUU-3, ON-TARGETplus SMARTpool siRNAs were used for: Cbl, CD2AP, 
clathrin, cortactin, dynamin, and endophilin.
Fly genetics
The dmim mutant was made using a modified version of “ends-out” homol-
ogous recombination (Gong and Golic, 2003). The donor vector was con-
structed by cloning PCR products of the homologous regions in the dmim 
genomic region upstream and downstream of the deleted exons (exons 3–10) 
into the pP[EndsOut2] vector (a gift from Dr. Jeff Sekelsky, University of 365 Missing-in-metastasis regulates endocytosis during cell migration • Quinones et al.
(Promega). GST beads containing the SH3 domain of cortactin were incu-
bated with equal amounts of CD2AP and increasing amounts of bacterially 
expressed full-length 6X-His MIM protein or 6X-His MIM lacking the C-terminal 
proline-rich domain. The beads were washed with PBST and run on SDS-
PAGE gels for Western blot analysis using rabbit anti-CD2AP (1:500; Cell 
Signaling Technology).
Online supplemental material
Fig. S1 shows ClustalW2 alignment of the I-BAR and WH2 domain of   
Drosophila, human, and mouse MIM as well as mouse ABBA and mouse 
IRSp53. Fig. S2 shows eclosion and hatching frequency deficiencies in 
dmim mutants as well as locomotor defects in the adults. Fig. S3 shows a 
comparison of staining patterns of cell–cell junctions, membranes, growth 
factor gradients, and the actin cytoskeleton between wild-type and dmim 
mutant egg chambers. Fig. S4 shows the effect of MIM knockdown on the 
formation of circular dorsal ruffles in vertebrate cell culture. Video 1 shows 
wild-type border cells migrating normally toward the oocyte (right). Video 2 
shows dmim mutant border cells fail to migrate toward the oocyte (right). 
Video 3 shows dmim/DMIM+ border cells migrating normally toward the 
oocyte (right). Online supplemental material is available at http://www 
.jcb.org/cgi/content/full/jcb.200910136/DC1.
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placed in Petri dishes with glass coverslip bottoms (MatTek), surrounded by 
halocarbon oil 700 (Sigma-Aldrich) and covered by the gas-permeable 
membrane from a Petriperm plate (Grenier Bio). Females were taken 1–3 d 
after eclosion and fed fresh yeast 1 d before dissection. Dissections were 
performed in Schneider’s Insect medium (Invitrogen) supplemented with 
15% fetal bovine serum (Sigma-Aldrich), 0.20 mg/ml
1 insulin (Sigma- 
Aldrich), 0.6x penicillin/streptomycin (Invitrogen), and 3 mM FM4-64 
(Invitrogen). Ovaries were removed, washed in dissection medium, and 
individual ovarioles were removed from the muscle sheath using fine dis-
section forceps. Imaging was performed using a microscope (LSM-510 
Meta; Carl Zeiss, Inc.) with a 340 1.3 NA Plan NeoFluor oil immersion 
objective. Two channels were acquired simultaneously: GFP (488-nm laser 
and 500–550-nm band-pass filter) and FM4-64 (488-nm laser and 560-nm 
long-pass filter). 7 sections were taken 5 µm apart with 5 min between 
stacks.  The  three  to  four  sections  covering  the  migrating  cluster  were 
merged for each time point using the Volocity 4 imaging software package 
(PerkinElmer). Videos were made using Volocity 4, and exported as Quick-
Time (.mov) files at 5 frames per second. Egg chambers were chosen in 
which border cells had clearly delaminated or were already migrating. For 
dye uptake assays, egg chambers were incubated in 9 µM FM4-64 dye in 
imaging medium for exactly 30 min before the first image was taken. For 
Dynasore (Sigma-Aldrich) inhibition of dynamin in the egg chambers, dis-
sected egg chambers were incubated in imaging medium containing 80 µM 
Dynasore for 1 h before the addition of FM4-64.
Live imaging calculations
The directionality index (DI) for large cellular extensions emanating from a 
border cell is calculated as (A  B)/(A + B), where A is the number of for-
ward extensions and B is the number of rearward extensions. Forward and 
rearward extensions are defined by which direction they point away from 
a vertical line on the dorsal ventral axis of the egg chamber. For the pur-
poses of this study, cell extensions are defined as transient, large cellular 
processes that are greater than one quarter of a border cell diameter in 
width at their base, and extend outward from the cell surface. Cellular 
filopodial-like projections are defined as cellular processes that are transient, 
less than one quarter of a cell diameter in width at the base, and extend 
from the cell surface. Tracking of cellular extensions/projections was per-
formed using the tracking module of the Volocity program. Each individual 
process was manually marked and tracked throughout each frame to cal-
culate the amount of time each process persisted. The number of projec-
tions was calculated by counting the number of projections along a 10-µm 
length of cell surface along a border cell. We are limited in the types of 
projection studies as our analyses cannot account for projections that form 
and dissociate faster than the 5-min time points collected. For FM4-64 dye 
uptake assays, images were taken over time of the border cell cluster and 
analyzed using ImageJ. A line drawn following the outside of the mem-
brane of a single border cell was used to select the area from which the in-
tensity measurements were calculated. The intensity measurement was then 
divided by the area selected to control for normal variations in border cell 
shapes and sizes. These analyses were all normalized to the overall inten-
sity of the entire egg chamber to account for differences in uptake through-
out the egg chamber itself. Measurements from single border cells within 
the same cluster were combined with measurements from cells of a different 
cluster for both technical and biological replicates within the analyses. 
A mutant dynamin (shi
K44A) and a small molecule inhibitor of dynamin were 
included as negative controls to show that dye uptake is dependent on 
clathrin-mediated endocytosis, and not just accumulation of the dye in the 
membrane over time.
GST pull-downs and coimmunoprecipitations
For GST pull-downs, cells were lysed in PBS with 1% NP-40, protease   
inhibitors, 1 mM Na3VO4, and 5 mM NaF for 30 min at 4°C. For coim-
munoprecipitations, cell lysates were generated using RIPA buffer (50 mM 
Tris-HCl, pH 8.0, 150 mM NaCl, 5 mM EDTA, 1% NP-40, 0.1% SDS, 
10% glycerol, 0.5% Na deoxycholate, 1 mM Na3VO4, and protease   
inhibitors) and precleared with Protein G PLUS-Agarose beads (Santa 
Cruz Biotechnology, Inc.) for 30 min at 4°C. The primary antibodies used 
were: rabbit anti-cortactin (1:1,000; Millipore), rabbit anti-MIM (1:500), 
mouse anti-CD2AP (1:500; Santa Cruz Biotechnology, Inc.), goat anti-
endophilin I (1:500; Santa Cruz Biotechnology, Inc.), mouse anti-Myc 
(1:500; Sigma-Aldrich), and rabbit anti-Myc (1:1,000; Santa Cruz Bio-
technology, Inc.).
Direct binding and competition assays
The coding sequence of CD2AP was cloned into pcDNA3.1 MHA. CD2AP 
protein was made using a TNT T7 Coupled Reticulocyte Lysate System JCB • VOLUME 189 • NUMBER 2 • 2010   366
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